Group, C. S., & Fonollosa Calduch, A. (2022). Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: A protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study.
Citación estilo ChicagoGroup, CoTHEIA Study, y Alejandro Fonollosa Calduch. Efficacy, Safety and Cost-effectiveness of Methotrexate, Adalimumab or Their Combination in Non-infectious Non-anterior Uveitis: A Protocol for a Multicentre, Randomised, Parallel Three Arms, Active-controlled, Phase III Open Label With Blinded Outcome Assessment Study. 2022.
Cita MLAGroup, CoTHEIA Study, y Alejandro Fonollosa Calduch. Efficacy, Safety and Cost-effectiveness of Methotrexate, Adalimumab or Their Combination in Non-infectious Non-anterior Uveitis: A Protocol for a Multicentre, Randomised, Parallel Three Arms, Active-controlled, Phase III Open Label With Blinded Outcome Assessment Study. 2022.